Healthcare system engagement and algorithm‐identified cancer incidence following initiation of a new medication.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 321, doi. 10.1002/pds.5556
- By:
- Publication type:
- Article
Works by D'Arcy, Monica E.
Results: 6
1
2
Rare germline deleterious variants increase susceptibility for lung cancer.
- Published in:
- Human Molecular Genetics, 2022, v. 31, n. 20, p. 3558, doi. 10.1093/hmg/ddac123
- By:
- Publication type:
- Article
3
Survival after a cancer diagnosis among solid organ transplant recipients in the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
4
Risk of Rare Cancers Among Solid Organ Transplant Recipients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
5
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
- Published in:
- 2020
- By:
- Publication type:
- journal article
6
Inflammatory diseases and risk of lung cancer among individuals who have never smoked.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56803-z
- By:
- Publication type:
- Article